Initial Chronic Human Validation Study: Subcutaneous Implantable (S-ICD) System

Mise à jour : Il y a 4 ans
Référence : NCT00853645

Femme et Homme

  • | Pays :
  • New Zealand
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary objective is to evaluate the safety and performance of the implanted S-ICD system. A maximum of 10 subjects were to be enrolled and followed for one month to collect data on the safety, efficacy, and performance of the implanted S-ICD system. Additionally, patient comfort will be assessed as will cosmetic outcome.


Critère d'inclusion

  • ACC/AHA/HRS Class I and II Indications for ICD Implantation

Liens